Biolase Profit Margin 2006-2019 | BIOL

Current and historical gross margin, operating margin and net profit margin for Biolase (BIOL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Biolase net profit margin as of June 30, 2019 is -47.46%.
Biolase Annual Profit Margins
Biolase Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.022B $0.046B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.211B 22.69
McKesson (MCK) United States $26.941B 10.41
AmerisourceBergen (ABC) United States $17.787B 12.23
Laboratory Of America Holdings (LH) United States $16.717B 15.83
Cooper (COO) United States $14.934B 25.27
Align Technology (ALGN) United States $14.406B 39.29
Cardinal Health (CAH) United States $14.316B 9.09
Straumann Holding AG (SAUHF) Switzerland $13.094B 0.00
DENTSPLY SIRONA (XRAY) United States $11.187B 23.65
West Pharmaceutical Services (WST) United States $10.570B 45.94
Henry Schein (HSIC) United States $9.363B 16.66
CONMED (CNMD) United States $2.865B 43.65
Patterson (PDCO) United States $1.671B 12.40
Merit Medical Systems (MMSI) United States $1.654B 17.23
Atrion (ATRI) United States $1.471B 40.92
STAAR Surgical (STAA) United States $1.328B 78.45
Antares Pharma (ATRS) United States $0.590B 0.00
Invacare (IVC) United States $0.248B 0.00
Lifevantage (LFVN) United States $0.192B 23.10
Endologix (ELGX) United States $0.069B 0.00
Pro-Dex (PDEX) United States $0.061B 19.48
Milestone Scientific (MLSS) United States $0.040B 0.00
Retractable Technologies (RVP) United States $0.030B 0.00